What is insufficient erythropoietin (EPO) production and why does inflammation increase ferritin levels in patients with chronic kidney disease (CKD) or chronic inflammation, such as rheumatoid arthritis (RA) or inflammatory bowel disease (IBD)?

Insufficient Erythropoietin Production and Inflammation-Induced Ferritin Elevation

What is Insufficient Erythropoietin Production?

Insufficient erythropoietin (EPO) production is the fundamental pathophysiologic mechanism causing anemia in chronic kidney disease, where failing kidneys cannot produce adequate amounts of this hormone needed to stimulate red blood cell production in bone marrow. 1

Mechanism of EPO Deficiency

• Specialized interstitial cells in the kidney cortex normally sense tissue hypoxia and produce erythropoietin in response to decreased oxygen delivery. 2

• In kidney disease, erythropoietin production becomes impaired, leading to erythropoietin deficiency and the apoptotic collapse of early erythropoiesis. 2, 1

• Erythropoietin normally binds to receptors on erythroid colony-forming units (CFU-Es) in bone marrow, salvaging these cells from preprogrammed cell death (apoptosis) and permitting their survival, division, and eventual expansion of red blood cell production. 2

• Without adequate erythropoietin, these early red blood cell progenitors undergo apoptosis, preventing the normal compensatory response to anemia. 2

Clinical Recognition

• The most common reason for inadequate reticulocyte response in CKD patients who are replete with iron, folate, and vitamin B12 is either insufficient erythropoietin production or inflammation. 2

• Recombinant human erythropoietin should be considered in patients with hemoglobin levels 2 g/dL less than the lower limit of normal, with a therapeutic hemoglobin target of 11-12 g/dL. 2

---

Why Inflammation Increases Ferritin Levels

Ferritin is an acute-phase protein that becomes elevated during inflammation independent of actual iron stores, making it an unreliable marker of iron status in inflammatory conditions. 2

Mechanisms of Inflammation-Induced Ferritin Elevation

• Inflammatory cytokines directly stimulate hepatic production and release of ferritin as part of the acute-phase response, causing ferritin levels to rise regardless of tissue iron stores. 3

• In hemodialysis patients, ferritin values above 500 ng/ml, especially when paradoxically combined with low iron saturation (<25%), are strongly associated with inflammation rather than true iron overload. 3

• The combination of high serum ferritin (≥500 ng/ml) and low iron saturation ratio (<25%) in maintenance hemodialysis patients shows higher odds ratios for elevated C-reactive protein (≥10 mg/L) after multivariate adjustment. 3

Impact on Iron Metabolism

• Inflammatory cytokines stimulate hepatic release of hepcidin, which simultaneously blocks iron absorption in the gut and iron release from resident macrophages, causing functional iron deficiency despite elevated ferritin. 2, 4

• This hepcidin-mediated iron sequestration decreases transferrin saturation and promotes iron-deficiency erythropoiesis even when total body iron stores appear adequate based on ferritin levels. 2

• Inflammation reduces the predictive value of ferritin for both iron status and responsiveness to iron therapy in CKD patients. 4

Clinical Implications

• In CKD patients with inflammation, interpretation of ferritin levels in isolation is difficult because ferritin functions as an acute-phase reactant and is often elevated irrespective of tissue iron stores. 2

• It may be useful to assess C-reactive protein levels to determine the contribution of inflammation to an elevated serum ferritin level in this population. 2

• Transferrin saturation may be a more reliable marker of iron sufficiency for erythropoiesis in CKD patients compared with ferritin, as it is less affected by inflammation. 2

• The upper limit of ferritin to predict iron overload is higher in CKD patients with inflammation than in those without, though MRI studies suggest lower cutoff levels than proposed by international guidelines. 4

Combined Effects on Anemia

• Inflammation impairs erythropoiesis through multiple mechanisms: inhibition of erythropoietin production, direct impairment of early erythroblast growth, promotion of immature erythroblast death through ligand-mediated destruction, and stimulation of hepatic hepcidin release. 2, 1

• The anemia of inflammation is characteristically hypoproliferative and frequently includes features suggesting iron-deficiency erythropoiesis despite elevated ferritin levels. 2